Acer Therapeutics Inc. (ACER) has 11 open-market insider trades by 6 insiders since 2017. The most active filer is Steve Aselage, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Reshentha Beeby | Dir10% Owner | — | 1 | $5.0M | 2018-08-01 |
| Gary Leatt | Dir10% Owner | — | 1 | $4.0M | 2017-12-12 |
| Chris Schelling | CEOPres | — | 2 | $3.0M | 2023-11-17 |
| Steve Aselage | Dir | — | 5 | $1.2M | 2023-11-17 |
| John Michael Dunn | Dir | — | 1 | $75K | 2023-11-17 |
| Donald Joseph | — | — | 1 | $50K | 2023-11-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Steve Aselage | Director | Buy | $1000K | 2022-11-29 |
| Chris Schelling | CEO & President | Buy | $2.0M | 2022-11-29 |
| Steve Aselage | Director | Buy | $21K | 2021-12-09 |
| Chris Schelling | CEO & President | Buy | $1000K | 2020-07-24 |
| Donald Joseph | CLO | Buy | $50K | 2020-07-24 |
| Steve Aselage | Director | Buy | $158K | 2020-07-24 |
Companies that share insiders with ACER, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John Michael Dunn | Director | Buy | $75K | 2020-07-24 |
| Steve Aselage | Director | Buy | $19K | 2019-07-03 |
| Reshentha Beeby | Director & 10% Owner | Buy | $5.0M | 2018-08-01 |
| Steve Aselage | Director | Buy | $24K | 2017-12-14 |
| Gary Leatt | Director & 10% Owner | Buy | $4.0M | 2017-12-12 |